Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-312026-03-31trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.32025-04-01falsedental care2truefalse 06954574 2025-04-01 2026-03-31 06954574 2024-04-01 2025-03-31 06954574 2026-03-31 06954574 2025-03-31 06954574 c:Director1 2025-04-01 2026-03-31 06954574 d:PlantMachinery 2025-04-01 2026-03-31 06954574 d:PlantMachinery 2026-03-31 06954574 d:PlantMachinery 2025-03-31 06954574 d:PlantMachinery d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 06954574 d:MotorVehicles 2025-04-01 2026-03-31 06954574 d:MotorVehicles 2026-03-31 06954574 d:MotorVehicles 2025-03-31 06954574 d:MotorVehicles d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 06954574 d:OfficeEquipment 2025-04-01 2026-03-31 06954574 d:OfficeEquipment 2026-03-31 06954574 d:OfficeEquipment 2025-03-31 06954574 d:OfficeEquipment d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 06954574 d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 06954574 d:CurrentFinancialInstruments 2026-03-31 06954574 d:CurrentFinancialInstruments 2025-03-31 06954574 d:Non-currentFinancialInstruments 2026-03-31 06954574 d:Non-currentFinancialInstruments 2025-03-31 06954574 d:CurrentFinancialInstruments d:WithinOneYear 2026-03-31 06954574 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 06954574 d:Non-currentFinancialInstruments d:AfterOneYear 2026-03-31 06954574 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 06954574 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2026-03-31 06954574 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-03-31 06954574 d:ShareCapital 2026-03-31 06954574 d:ShareCapital 2025-03-31 06954574 d:RetainedEarningsAccumulatedLosses 2026-03-31 06954574 d:RetainedEarningsAccumulatedLosses 2025-03-31 06954574 c:FRS102 2025-04-01 2026-03-31 06954574 c:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 06954574 c:FullAccounts 2025-04-01 2026-03-31 06954574 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 06954574 2 2025-04-01 2026-03-31 06954574 e:PoundSterling 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure

Registered number: 06954574










P & P LABORATORIES LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2026

 
P & P LABORATORIES LIMITED
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF P & P LABORATORIES LIMITED
FOR THE YEAR ENDED 31 MARCH 2026

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of P & P Laboratories Limited for the year ended 31 March 2026 which comprise the Statement of financial position and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the director of P & P Laboratories Limited in accordance with the terms of our engagement letter dated 1st December 2021Our work has been undertaken solely to prepare for your approval the financial statements of P & P Laboratories Limited and state those matters that we have agreed to state to the director of P & P Laboratories Limited in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than P & P Laboratories Limited and its director for our work or for this report. 

It is your duty to ensure that P & P Laboratories Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of P & P Laboratories Limited. You consider that P & P Laboratories Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of P & P Laboratories Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



McColes & Co (Herts) Ltd
 
Chartered Accountants
  
First Floor
28 Whitehorse Street
Baldock
Hertfordshire
SG7 6QQ
16 July 2026
Page 1

 
P & P LABORATORIES LIMITED
REGISTERED NUMBER: 06954574

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2026

2026
2025
£
£

Fixed assets
  

Tangible assets
 4 
13,282
16,410

  
13,282
16,410

Current assets
  

Debtors: amounts falling due within one year
 5 
4,904
-

Cash at bank and in hand
  
63,695
73,729

  
68,599
73,729

Creditors: amounts falling due within one year
 6 
(26,895)
(28,277)

Net current assets
  
 
 
41,704
 
 
45,451

Total assets less current liabilities
  
54,986
61,861

Creditors: amounts falling due after more than one year
 7 
(2,366)
(7,803)

  

Net assets
  
52,620
54,058


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
52,520
53,958

  
52,620
54,058


Page 2

 
P & P LABORATORIES LIMITED
REGISTERED NUMBER: 06954574
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2026

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 July 2026.




B Paktinat
Director

The notes on pages 4 to 9 form part of these financial statements.

Page 3

 
P & P LABORATORIES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The presentational currency of the Company is GBP.

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
1.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
1.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
1.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
1.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
1.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 4

 
P & P LABORATORIES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.Accounting policies (continued)

 
1.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

 
1.8

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.


 
1.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the following methods.

Depreciation is provided on the following basis:

Plant & machinery
-
25% reducing balance
Motor vehicles
-
25% reducing balance
Office equipment
-
33% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
1.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 5

 
P & P LABORATORIES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.Accounting policies (continued)

 
1.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
1.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
1.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


2.


General information

The company is a private company, limited by shares and registered in England.

Its registered number is: 06954574

Its Registered Office is: 

2 Bancroft Court
Hitchin
Hertfordshire
SG5 1LH


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2025 - 3).

Page 6

 
P & P LABORATORIES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

4.


Tangible fixed assets


Plant & machinery
Motor vehicles
Office equipment
Total

£
£
£
£



Cost or valuation


At 1 April 2025
2,914
38,000
4,781
45,695


Additions
-
-
1,741
1,741



At 31 March 2026

2,914
38,000
6,522
47,436



Depreciation


At 1 April 2025
2,801
21,969
4,515
29,285


Charge for the year on owned assets
28
4,008
833
4,869



At 31 March 2026

2,829
25,977
5,348
34,154



Net book value



At 31 March 2026
85
12,023
1,174
13,282



At 31 March 2025
113
16,031
266
16,410


5.


Debtors

2026
2025
£
£


Trade debtors
2,354
-

Prepayments and accrued income
2,550
-

4,904
-


Page 7

 
P & P LABORATORIES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

6.


Creditors: Amounts falling due within one year

2026
2025
£
£

Bank overdrafts
97
-

Bank loans
1,000
4,000

Trade creditors
329
654

Corporation tax
7,604
4,972

Other taxation and social security
228
-

Obligations under finance lease and hire purchase contracts
4,437
4,043

Other creditors
9,453
10,955

Accruals and deferred income
3,747
3,653

26,895
28,277



7.


Creditors: Amounts falling due after more than one year

2026
2025
£
£

Bank loans
-
1,000

Net obligations under finance leases and hire purchase contracts
2,366
6,803

2,366
7,803


Page 8

 
P & P LABORATORIES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

8.


Loans


Analysis of the maturity of loans is given below:


2026
2025
£
£

Amounts falling due within one year

Bank loans
1,000
4,000


1,000
4,000

Amounts falling due 1-2 years

Bank loans
-
1,000


-
1,000



1,000
5,000



9.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company  to the fund and amounted to £8,329 (2025 - £6,967) . Contributions totalling £694 (2025 - £694) were payable to the fund at the reporting date and are included in creditors.


10.


Related party transactions

The amount due to the Director and included in Other Creditors is £434 (2025: £1,140).  The loan does not attract a rate of interest and is repayable on demand.

 
Page 9